Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists
- 1 March 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 129, 310-324
Abstract
No abstract availableKeywords
Funding Information
- National Key Program of China (2012ZX09103101-022, 2012ZX10001-006)
- National Natural Science Foundation of China (81102483, 81472780)
- Innovation Team of Natural Science Foundation of Department of Education of Guizhou Province (QJHRCTDZ [2015] 57))
This publication has 52 references indexed in Scilit:
- Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFβ To Degrade APOBEC3 Restriction FactorsJournal of Virology, 2012
- Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infectionNature, 2011
- Inducible APOBEC3G-Vif Double Stable Cell Line as a High-Throughput Screening Platform To Identify Antiviral CompoundsAntimicrobial Agents and Chemotherapy, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Regulation of APOBEC3 Proteins by a Novel YXXL Motif in Human Immunodeficiency Virus Type 1 Vif and Simian Immunodeficiency Virus SIVagm VifJournal of Virology, 2009
- Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 VifJournal of Virology, 2009
- Small-molecule inhibition of HIV-1 VifNature Biotechnology, 2008
- Cytidine Deamination of Retroviral DNA by Diverse APOBEC ProteinsCurrent Biology, 2004
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002